Intercept pharmaceuticals, inc. (ICPT)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Dec'11
Assets
Current assets:
Cash and cash equivalents

41,408

70,055

63,377

93,501

54,724

43,248

59,382

77,720

48,871

70,013

120,244

62,031

66,950

43,675

105,216

51,701

49,205

32,742

72,354

88,257

104,366

20,023

18,059

44,961

11,210

13,363

33,492

52,140

31,711

45,511

35,971

17,707

Restricted cash

5,011

4,725

-

-

-

-

-

-

-

-

-

-

-

-

-

45,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment debt securities, available-for-sale

507,628

582,567

648,994

665,016

298,818

392,912

429,711

460,618

277,221

344,904

372,506

488,274

541,063

645,710

674,743

387,786

507,655

595,313

623,354

644,062

297,626

219,701

254,747

254,069

122,894

131,468

123,260

109,658

72,508

64,682

-

0

Accounts receivable, net of allowance for credit losses of $179 and $0, respectively

43,857

38,044

32,822

36,360

29,440

25,700

22,080

19,509

16,944

16,501

14,487

13,230

10,625

9,126

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

77

-

Prepaid expenses and other current assets

30,287

25,924

23,891

24,312

19,819

20,571

17,745

19,893

20,809

16,889

14,278

15,025

16,348

9,354

14,622

20,781

18,087

13,638

6,830

8,637

8,392

6,104

6,282

7,617

4,796

2,732

1,601

1,664

1,572

1,584

2,105

1,196

Total current assets

628,191

721,315

769,084

819,189

402,801

482,425

528,918

577,740

363,845

448,307

521,515

578,560

634,986

707,865

794,581

505,267

574,947

641,693

702,538

740,956

410,384

245,828

279,088

306,648

138,901

147,564

158,354

163,463

105,792

111,778

38,154

18,904

Fixed assets, net

4,846

5,202

5,973

6,814

7,464

10,411

11,322

12,453

14,074

16,184

18,141

17,659

14,518

11,295

11,865

12,530

11,770

10,047

10,207

9,383

7,531

5,852

5,131

2,163

1,910

1,672

190

136

134

148

157

311

Inventory

10,260

8,462

9,348

7,686

7,370

7,108

7,475

5,813

7,938

3,480

3,897

2,682

2,116

2,279

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits

6,644

6,661

8,205

8,374

8,340

9,223

9,238

8,908

7,961

16,376

16,873

16,844

16,400

17,814

5,821

6,377

6,658

4,018

4,002

3,517

3,726

2,469

1,800

1,957

1,082

1,081

346

268

268

251

257

254

Other assets

12,440

13,246

9,484

10,906

12,283

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

662,381

754,886

802,094

852,969

438,258

509,167

556,953

604,914

393,818

484,347

560,426

615,745

668,020

739,253

812,267

524,174

593,375

655,758

716,747

753,856

421,642

254,149

286,020

310,768

141,894

150,318

158,891

163,868

106,196

112,178

38,569

19,470

Liabilities and Stockholders' (Deficit) Equity
Current liabilities:
Accounts payable, accrued expenses and other liabilities

144,518

153,968

133,295

115,562

101,886

105,109

83,058

79,606

74,087

94,777

82,070

73,260

62,923

65,551

46,854

42,693

42,470

45,591

30,401

22,006

16,371

13,459

14,714

10,138

8,763

7,259

5,079

3,671

3,225

3,745

4,090

1,504

Short-term interest payable

5,450

8,037

5,463

8,050

3,738

7,475

3,737

7,475

3,737

7,475

3,737

7,475

3,738

7,267

3,738

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55,000

55,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term portion of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

276,738

-

809

1,871

4,786

7,596

334

0

Short-term portion of deferred revenue

-

-

1,216

1,622

2,717

1,621

1,622

1,622

1,622

1,782

1,782

6,836

6,019

5,694

3,935

4,462

1,782

1,782

1,782

1,782

1,781

1,782

1,781

1,781

1,621

1,621

1,621

1,621

1,621

1,621

1,621

2,446

Short-term portion of capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

81

Total current liabilities

149,968

162,005

139,974

125,234

108,341

114,205

88,417

88,703

79,446

104,034

87,589

87,571

72,680

78,512

54,527

102,155

99,252

47,373

32,183

23,788

18,152

15,241

16,495

11,920

287,124

8,881

7,511

7,164

9,633

12,964

6,046

4,032

Long-term liabilities:
Long-term debt

538,968

532,078

525,339

545,009

375,351

371,250

367,233

363,300

359,449

355,677

351,984

348,367

344,825

341,356

337,898

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term other liabilities

8,164

9,247

6,046

7,523

9,162

3,771

4,278

4,713

5,171

5,578

6,068

6,540

6,268

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of deferred revenue

-

-

-

-

405

811

1,216

1,622

2,027

2,672

3,118

3,563

4,009

4,453

4,899

5,345

5,790

6,236

6,681

7,126

7,571

8,017

8,462

8,908

8,513

8,918

9,324

9,729

10,135

10,540

10,945

12,162

Long-term portion of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50,112

51,093

30,702

25,627

22,762

5,939

5,835

Total liabilities

697,100

703,330

671,359

677,766

493,259

490,037

461,144

458,338

446,093

467,961

448,759

446,041

427,782

424,321

397,324

107,500

105,042

53,609

38,864

30,914

25,724

23,258

24,958

20,828

295,637

67,912

67,928

47,597

45,395

46,266

22,932

22,030

Stockholders' equity:
Preferred stock par value $0.001 per share; 5,000,000 shares authorized; none outstanding as of September 30, 2017 and December 31, 2016, respectively

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock par value $0.001 per share; 45,000,000 shares authorized; 32,937,431 and 32,853,066 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

33

33

33

33

30

30

30

29

25

25

25

25

25

25

25

25

25

24

24

24

22

21

21

21

19

19

19

19

16

16

3

3

Additional paid-in capital

2,185,501

2,176,133

2,157,080

2,116,481

1,815,193

1,800,144

1,788,205

1,774,955

1,499,476

1,486,690

1,470,545

1,456,878

1,441,501

1,426,168

1,406,260

1,317,412

1,311,739

1,300,008

1,286,740

1,280,187

904,714

700,355

695,621

688,486

289,834

268,302

264,519

258,232

189,422

184,100

103,084

72,133

Accumulated other comprehensive loss, net

-3,804

-1,144

-1,070

-836

-1,169

-2,259

-1,646

-2,082

-643

-786

-632

-1,529

-2,182

-2,801

-2,924

-1,160

-1,126

-2,253

-1,504

-788

-230

-284

-203

-33

43

59

31

-109

-245

-21

0

-184

Accumulated deficit

-2,216,449

-2,123,466

-2,025,308

-1,940,475

-1,869,055

-1,778,785

-1,690,780

-1,626,326

-1,551,133

-1,469,543

-1,358,271

-1,285,670

-1,199,106

-1,108,460

-988,418

-899,603

-822,305

-695,630

-607,377

-556,481

-508,587

-469,202

434,377

-398,534

443,641

-185,975

173,607

141,870

128,393

118,183

87,492

74,540

Total stockholders' (deficit) equity

-34,719

51,556

130,735

175,203

-55,001

19,130

95,809

146,576

-52,275

16,386

111,667

169,704

240,238

314,932

414,943

416,674

488,333

602,149

677,883

722,942

395,918

230,891

261,062

289,940

-153,743

82,406

90,962

116,271

60,800

65,911

15,637

-2,559

Total liabilities and stockholders' (deficit) equity

662,381

754,886

802,094

852,969

438,258

509,167

556,953

604,914

393,818

484,347

560,426

615,745

668,020

739,253

812,267

524,174

593,375

655,758

716,747

753,856

421,642

254,149

286,020

310,768

141,894

150,318

158,891

163,868

106,196

112,178

38,569

19,470